Healthcare / Diagnostics & ResearchUpdated 2026-05-10 22:07 UTC

ETR/QIA stock hub

ETR/QIA has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

ETR/QIAis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

5.8B

Deutsche Börse Xetra

Market data

Live price

Current market quote for this ticker.

Current price

ETR/QIA

In the news

Latest news · ETR/QIA

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/E13.1

P25 12.3P50 15.7P75 20.2

Trailing P/E16.6

P25 16.4P50 20.9P75 30.4

ROE11.9

P25 -6.7P50 8.5P75 17.2

ROIC10.8

P25 -1.7P50 8.5P75 17.4

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All ETR/QIA market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

243

Groups with data

Currency

USD

Showing 243 of 243 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	Netherlands
Country code	DE
Employees	5,654
Employees Change	258%
Employees Change Percent	4.78
Enterprise value	EUR 6.7B
Exchange	Deutsche Börse Xetra
Financial currency	USD
First seen	2026-05-10
Industry	Diagnostics & Research
Isin	NL0015002SN0
Last refreshed	2026-05-10
Market cap	EUR 5.8B
Price	EUR 28.12
Price currency	EUR
Rev Per Employee	329,414.38x
Sector	Healthcare
Sic	3826
Symbol	etr/QIA
Website	https://www.qiagen.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	6.01%
EV Earnings	19.08x
EV/EBIT	14.35x
EV/EBITDA	10.34x
EV/FCF	18.66x
EV/Sales	3.73x
FCF yield	6.14%
Forward P/E	13.07x
P/B ratio	2.01x
P/E ratio	16.64x
P/S ratio	3.19x
PE Ratio10 Y	74.68x
PE Ratio3 Y	54.69x
PE Ratio5 Y	42.86x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	25.8%
EBITDA Margin	34.52%
FCF margin	19.59%
Gross margin	66%
Gross Profit	EUR 1.2B
Gross Profit Growth	3.57%
Gross Profit Growth Q	-0.96%
Gross Profit Growth3 Y	1.14%
Gross Profit Growth5 Y	-0.57%
Net Income	EUR 348.8M
Net Income Growth	329.32%
Net Income Growth Q	-25.03%
Net Income Growth Years	1%
Net Income Growth3 Y	4.45%
Net Income Growth5 Y	-2.16%
Pretax Margin	21.75%
Profit Margin	19.16%
Profit Per Employee	EUR 63,119
Profitable Years	6
ROA	5.98
Roa5y	5.61
ROCE	10.21
ROE	11.93
Roe5y	11.16
ROIC	10.79
Roic5y	10.85

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	4.03%
Cagr15y	4.33%
Cagr1y	-24.21%
Cagr20y	4.33%
Cagr3y	-12.21%
Cagr5y	-6.65%
Div CAGR3	19.39%
Div CAGR5	11.22%
EPS Growth	338.2
EPS Growth Q	-24.55
EPS Growth Years	1
EPS Growth3 Y	4.12
EPS Growth5 Y	-1.94
FCF Growth	-18.69%
FCF Growth Q	-43.92%
FCF Growth3 Y	-2.72%
FCF Growth5 Y	-0.01%
OCF Growth	-9.56%
OCF Growth Q	-27.99%
OCF Growth10 Y	7.33%
OCF Growth3 Y	2%
OCF Growth5 Y	1.52%
Revenue Growth	4.79x
Revenue Growth Q	1.83x
Revenue Growth Quarters	8x
Revenue Growth Years	2x
Revenue Growth3 Y	1.65x
Revenue Growth5 Y	0.32x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	EUR 0.37
Assets	EUR 5B
Cash	EUR 560.5M
Current Assets	EUR 1.3B
Current Liabilities	EUR 406.3M
Debt	EUR 1.4B
Debt EBITDA	EUR 2.19
Debt Equity	EUR 0.49
Debt FCF	EUR 4
Equity	EUR 2.9B
Interest Coverage	14.63
Liabilities	EUR 2.1B
Long Term Assets	EUR 3.7B
Long Term Liabilities	EUR 1.7B
Net Cash	EUR -867.5M
Net Cash By Market Cap	EUR -14.94
Net Debt EBITDA	EUR 1.38
Net Debt Equity	EUR 0.3
Net Debt FCF	EUR 2.43
Tangible Book Value	EUR 232.6M
Tangible Book Value Per Share	EUR 1.13
WACC	6.64

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	3.21
Inventory Turnover	2.42
Net Working Capital	EUR 359.8M
Quick ratio	2.18
Working Capital	EUR 920.3M
Working Capital Turnover	EUR 1.59

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-0.17%
Dividend Growth	71.66%
Dividend Growth Years	3%
Dividend per share	EUR 2.18
Dividend Years	3
Dividend Yield	7.66%
Ex Div Date	2026-01-08
Last Dividend	EUR 1.96
Payout Frequency	Semi-Annual
Payout Ratio	13.49%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	48.44%
1Y total return	-24.2%
200-day SMA	40.62
3Y total return	-32.34%
50-day SMA	34.94
50-day SMA vs 200-day SMA	50under200
5Y total return	-29.11%
All Time High	71.05
All Time High Change	-60.43%
All Time High Date	2000-07-18
All Time Low	4.87
All Time Low Change	477.55%
All Time Low Date	2002-10-01
ATR	0.99
Beta	0.64
Ch YTD	-31.26
High	28.65
High52	47.6
High52 Date	2026-01-22
High52ch	-40.93%
Low	28.03
Low52	28.03
Low52 Date	2026-05-08
Low52ch	0.25%
Ma50ch	-19.53%
Price vs 200-day SMA	-30.78%
RSI	21.82
RSI Monthly	31.74
RSI Weekly	26.48
Sharpe ratio	-1.02x
Sortino ratio	-1.2
Total Return	7.49%
Tr YTD	-27.74
Tr15y	88.82%
Tr1m	-18.01%
Tr1w	-2.9%
Tr3m	-34.87%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	EUR 469.6M
Operating Income Growth	3.5
Operating Income Growth Q	-9.77
Operating Income Growth3 Y	5.11
Operating Income Growth5 Y	-2.92
Operating margin	25.8

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	205,449,013%
Net Borrowing	176,504,138.3
Shares Insiders	0.56%
Shares Institutions	74.56%
Shares Qo Q	0.57%
Shares Yo Y	0.17%
Short Ratio	2.95

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	EUR 315.2M
Average Volume	663,183.6x
Bv Per Share	14.01
CAPEX	EUR -177M
Ch10y	27.63
Ch15y	62.36
Ch1m	-18.01
Ch1w	-2.9
Ch1y	-28.26
Ch20y	100.6
Ch3m	-34.87
Ch3y	-39.55
Ch5y	-36.67
Ch6m	-28.46
Change	-1.33%
Change From Open	-1.49
Close	28.5
Days Gap	0.14
Depreciation Amortization	155,218,596.1
Dollar Volume	15,675,433.9
Earnings Date	2026-05-06
EBIT	EUR 469.6M
EBITDA	EUR 628.4M
EPS	EUR 1.68
F Score	5
FCF	EUR 356.6M
FCF EV Yield	5.36x
Financing CF	-343,390,956
Fiscal Year End	December
Founded	1,984
Goodwill	2,286,088,592.8
Graham Number	23.06364
Graham Upside	-17.97
Income Tax	EUR 47.2M
Investing CF	-185,503,328
Is Primary Listing	0
Last Earnings Date	2026-05-06
Last Report Date	2026-03-31
Last Split Date	2026-01-08
Last Split Type	Reverse
Lynch Fair Value	EUR 8.45
Lynch Upside	-69.96
Ma150	39.8
Ma150ch	-29.36%
Ma20	32.21
Ma20ch	-12.7%
Net CF	6,533,371
Next Earnings Date	2026-08-03
Open	28.54
P FCF Ratio	16.28
P OCF Ratio	10.88
Payment Date	2026-01-08
Position In Range	13.71
Ppne	775,706,310
Price Date	2026-05-08
Price EBITDA	EUR 9.24
Ptbv Ratio	24.95
Relative Volume	0.84x
Revenue	1,820,343,880x
SBC By Revenue	2.27x
Share Based Comp	41,380,618
Tax By Revenue	2.59x
Tax Rate	11.91%
Tr20y	133.33%
Tr6m	-24.8%
Volume	557,547
Z Score	4

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

ETR/QIA dividend yield, growth & safety

Yield, payout sustainability, and the multi-year growth streak.

Dividend yield

+7.7%

$2.18 annual per share

Payout ratio

+13.5%

Share of earnings returned as dividends. Below 60% is generally sustainable.

5Y dividend CAGR

+11.2%

3 consecutive years of growth

Total shareholder yield

+7.5%

Next ex-dividend date: 2026-01-08

Performance

ETR/QIA stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns ETR/QIA?

Insider, institutional, and short-interest positioning.

Institutional ownership

+74.6%

Share of float held by funds and institutions

Insider ownership

+0.6%

Stake held by company insiders. Higher generally signals alignment.

Negative means the company is buying back shares.

Technical

ETR/QIA momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

21.8

Below 30: short-term oversold

Price vs 200-day MA

-30.8%

50/200-day relationship not available

Beta (5Y)

0.64

Less volatile than the market

Sharpe ratio

-1.02

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About ETR/QIA

Hub-level FAQ points readers to the deeper analysis pages.

What is the current etr/QIA stock rating?

etr/QIA is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full etr/QIA analysis?

The full report lives at /stocks/etr/QIA/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for etr/QIA?

The latest report frames etr/QIA around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the etr/QIA page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.